TSH Biopharm Limited Goodwill

The latest goodwill for 8432.TWO is $250M as of June 2026. That compares with $250M in the prior-year period — up 0.0% year over year. Investors often review this figure alongside TSH Biopharm Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, 8432.TWO's goodwill moved from $250M to $250M — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TSH Biopharm Limited's operating scale or balance-sheet position.

A goodwill figure of $250M for 8432.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 8432.TWO's goodwill ($250M), review year-over-year change from $250M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.